From: Relationship between efficacy and common metabolic parameters in first-treatment drug-naïve patients with early non-response schizophrenia: a retrospective study
N, %
Baseline
2 weeks later
Reduction rate (%)
Total score
143, 100
89.15 ± 11.19
76.14 ± 14.61
22.62 ± 17.84
Group A
70, 48.95
86.94 ± 10.20
66.06 ± 10.75
37.07 ± 14.05
Group B
73, 51.05
91.27 ± 11.74
85.82 ± 10.79
8.77 ± 6.44